The FDA has issued a mandate to update the risk section of the drug label for Saphris after learning that 52 patients suffered allergic reactions ranging from rashes to anaphylactic shock.
480.905.9208
Toll Free:
1.888.905.9208
May 17, 2012 Diabetes, Obesity & Hypertension During Pregnancy May Increase Risk of Autism (5.17.12) A recent study concluded that pregnant women who are diabetic, obese or hypertensive (high blood...
May 15, 2012 Carbonated Beverages Increase Risk of Stroke (5.15.12) Believe it or not, both diet and regular soda consumption is suspected to significantly raise...
May 10, 2012 Liberation Therapy/Procedure Used to Treat Chronic Cerebrospial Venous Insufficiency May Be Dangerous, Says FDA (5.10.12) The FDA has issued an alert regarding Liberation Therapy/Procedure saying that it is an experimental...
April 17, 2012 C-Reactive Protein May Be Reliable Indicator for Preterm Premature Rupture of Membranes (PPROM) (4.17.12) Recent data demonstrate that elevated maternal C-reactive protein in the early stage of pregnancy suggests...
April 10, 2012 Synthetic Progesterone (Drospirenone) Contained in Birth Control Pills Possibly Linked to Increased Risk of Clotting (4.10.12) The FDA warns that birth control pills containing drospirenone may increase the risk of blood...
April 10, 2012 Honey and Yogurt Mixture Proves Effective in Treating Vulvovaginal Candidiasis During Pregnancy (4.10.12) A recent small study demonstrated that honey mixed with yogurt was effective in treating vulvovaginal...